Compounds > almotriptan
Page last updated: 2024-09-03

almotriptan and nevirapine

almotriptan has been researched along with nevirapine in 4 studies

Compound Research Comparison

Studies
(almotriptan)		Trials
(almotriptan)		Recent Studies (post-2010)
(almotriptan)		Studies
(nevirapine)		Trials
(nevirapine)		Recent Studies (post-2010) (nevirapine)
18859423,2125091,108

Protein Interaction Comparison

ProteinTaxonomyalmotriptan (IC50)nevirapine (IC50)
Chain B, Hiv-1 Reverse TranscriptaseHuman immunodeficiency virus 10.08
Chain A, Hiv-1 Reverse TranscriptaseHuman immunodeficiency virus 10.08
Chain A, Hiv-1 Reverse TranscriptaseHuman immunodeficiency virus 10.08
Chain A, Hiv-1 Reverse TranscriptaseHuman immunodeficiency virus 10.08
Chain B, Hiv-1 Reverse TranscriptaseHuman immunodeficiency virus 10.08
Chain A, Reverse transcriptase/ribonuclease HHuman immunodeficiency virus 11.165
Prothrombin Bos taurus (cattle)1.15
Gag-Pol polyproteinHuman immunodeficiency virus type 1 BH101.4504
Gag-Pol polyproteinHuman immunodeficiency virus type 2 (ISOLATE ROD)2.05
Gag-Pol polyproteinHIV-1 M:B_HXB2R1.4353
Imidazoleglycerol-phosphate dehydrataseSaccharomyces cerevisiae S288C1.7
Cytochrome P450 3A4Homo sapiens (human)0.181
Cytochrome P450 2C9 Homo sapiens (human)0.181
Gag-Pol polyproteinHuman immunodeficiency virus type 1 (NEW YORK-5 ISOLATE)0.69
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)0.7
Microsomal triglyceride transfer protein large subunitHomo sapiens (human)5.75
Disintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)0.18
Reverse transcriptase/RNaseH Human immunodeficiency virus 12.071
Protease Human immunodeficiency virus 10.101
Reverse transcriptase Human immunodeficiency virus 13.995

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for almotriptan and nevirapine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for almotriptan and nevirapine

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009